The First Global Summit on Precision Diagnosis for Prostate Cancer is a unique multi-disciplinary forum organized to fill the currently existing gaps among the thought leaders working on cutting-edge diagnostic tools (e.g., biomarkers, imaging, genomics, genetics) in order to educate the key health care stakeholders, create a consensus-based joint strategy, and stimulate novel ideas for improving screening, early detection and treatment.
We would welcome sponsorship of the First Global Summit on Precision Diagnosis for Prostate Cancer.
With your support, we will address the key challenge in prostate cancer care: The need to improve early detection (and exclusion) of clinically significant prostate cancer, which has a potential to progress, cause metastases and death.
This event has brought together the key multi-disciplinary thought leaders at the forefront of research and development of the leading diagnostic tools, including standard approaches to screening and early detection (e.g., PSA) and emerging novel solutions (e.g., imaging, biomarkers, genetics/genomics, and molecular pathology, etc).
Together, we will expedite advancement and clinical implementation of precision diagnostics, which will end the current unacceptable extent of unnecessary and failed biopsies and treatment and create a new future of precision, personalized prostate cancer care.
-
Please see the Scientific Program & Event Schedule.
-
For our outstanding speakers, please see Selected Speakers / Flyer.
-
For our event plan and clinical aims, please see Event Description.
-
Learn more about Hands-on Workshop on Prostate MRI, PI-RADS Scoring and Fusion Biopsy, Sponsored by Hitachi.
-
Please also see Sponsorship Levels.
-
Please also see Refund Policy for the Registration Fee.
